CA3118954C - Pamoate de ketamine et son utilisation - Google Patents

Pamoate de ketamine et son utilisation

Info

Publication number
CA3118954C
CA3118954C CA3118954A CA3118954A CA3118954C CA 3118954 C CA3118954 C CA 3118954C CA 3118954 A CA3118954 A CA 3118954A CA 3118954 A CA3118954 A CA 3118954A CA 3118954 C CA3118954 C CA 3118954C
Authority
CA
Canada
Prior art keywords
ketamine
pamoate
pamoate salt
pharmaceutical composition
xrpd pattern
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3118954A
Other languages
English (en)
Other versions
CA3118954A1 (fr
Inventor
Tong-Ho Lin
Yung-Shun Wen
Chia-Hsien Chen
Wei-Ju Chang
Original Assignee
Alar Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alar Pharmaceuticals Inc filed Critical Alar Pharmaceuticals Inc
Priority claimed from PCT/CN2020/071404 external-priority patent/WO2020143762A1/fr
Publication of CA3118954A1 publication Critical patent/CA3118954A1/fr
Application granted granted Critical
Publication of CA3118954C publication Critical patent/CA3118954C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne des sels de pamoate de kétamine ayant une stoechiométrie de 2 : 1 de pamoate de kétamine, comprenant R, S-pamoate de kétamine, S-pamoate de kétamine, ou R-pamoate de kétamine, et des formes cristallines ou amorphes des sels de pamoate, et ayant une excellente sécurité ainsi que des propriétés pour des utilisations pharmaceutiques. L'invention concerne également des compositions pharmaceutiques comprenant les sels de pamoate de kétamine et leurs utilisations dans le traitement d'une maladie du SNC ou servant d'anesthésique.
CA3118954A 2019-01-11 2020-01-10 Pamoate de ketamine et son utilisation Active CA3118954C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962791058P 2019-01-11 2019-01-11
US62/791,058 2019-01-11
US201962871763P 2019-07-09 2019-07-09
US62/871,763 2019-07-09
PCT/CN2020/071404 WO2020143762A1 (fr) 2019-01-11 2020-01-10 Pamoate de kétamine et son utilisation

Publications (2)

Publication Number Publication Date
CA3118954A1 CA3118954A1 (fr) 2020-07-16
CA3118954C true CA3118954C (fr) 2026-02-03

Family

ID=

Similar Documents

Publication Publication Date Title
AU2020206826B2 (en) Ketamine pamoate and use thereof
JP7764373B2 (ja) ケタミンパモエート塩の長時間作用型注射用製剤
JP6236077B2 (ja) 持続時間が超短期、短期、または中期の非対称性逆転可能神経筋遮断物質
KR20100049663A (ko) 마취제-절감 효과를 달성하기 위해 ｎｍｄａ 길항제를 사용하는 조성물 및 방법
JP5198293B2 (ja) アミノアルコール誘導体を有効成分とする脱髄性疾患の治療剤又は予防剤
CA3118954C (fr) Pamoate de ketamine et son utilisation
RU2825336C2 (ru) Кетамин памоат и его применение
WO2017129061A1 (fr) Application de dérivés substitués du cinnamamide dans la préparation de médicaments contre l'anxiété
BR112021013340B1 (pt) Sal de pamoato de cetamina e usos de uma composição farmacêutica compreendendo o referido sal
CN112521358B (zh) 一种长效低成瘾性hnk衍生物在制备药物中的应用
HK40049627A (en) Ketamine pamoate and use thereof
HK40049627B (zh) 氯胺酮双羟萘酸盐及其用途
CN116987091B (zh) 用于治疗癫痫发作疾病的药物及其制备方法
JP7579595B2 (ja) 長時間作用性の低嗜癖性ｈｎｋ誘導体及びその製造方法
WO2025019590A2 (fr) Chimères ciblant la protéolyse pour traiter la neurodégénérescence
WO2025019604A2 (fr) Chimères ciblant la protéolyse pour le traitement de la neurodégénérescence
HK40062327B (zh) 氯胺酮双羟萘酸盐的长效注射剂型
JP2017509617A (ja) 抗異痛活性および抗痛覚過敏活性を有する新規化合物